VBI Vaccines Inc/BC Annual Operating Income (Loss) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
VBI Vaccines Inc/BC quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
  • VBI Vaccines Inc/BC Operating Income (Loss) for the quarter ending March 31, 2024 was -$11.8M, a 39.8% increase year-over-year.
  • VBI Vaccines Inc/BC Operating Income (Loss) for the twelve months ending March 31, 2024 was -$72.2M, a 15.5% increase year-over-year.
  • VBI Vaccines Inc/BC annual Operating Income (Loss) for 2023 was -$79.9M, a 2.33% increase from 2022.
  • VBI Vaccines Inc/BC annual Operating Income (Loss) for 2022 was -$81.8M, a 20.3% decline from 2021.
  • VBI Vaccines Inc/BC annual Operating Income (Loss) for 2021 was -$68M, a 56% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$79.9M +$1.91M +2.33% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$81.8M -$13.8M -20.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 -$68M -$24.4M -56% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-13
2020 -$43.6M +$8.78M +16.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
2019 -$52.4M +$8.01M +13.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 -$60.4M -$23.1M -62% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 -$37.3M -$12.4M -50% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-25
2016 -$24.9M -$1.09M -4.59% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-26
2015 -$23.8M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.